Ribosomal protein L22-like1 (RPL22L1) mediates sorafenib sensitivity via ERK in hepatocellular carcinoma

Precision medicine in hepatocellular carcinoma (HCC) relies on validated biomarkers that help subgroup patients for targeted treatment. Here, we identified a novel candidate oncogene, ribosomal protein L22-like1 (RPL22L1), which was markedly elevated in HCC, contributed to HCC malignancy and adverse...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Dongmei, Zhou, Yunzhen, Ma, Yanan, Jiang, Ping, Lv, Hongchao, Liu, Sijia, Mu, Yu, Zhou, Chong, Xiao, Shan, Ji, Guohua, Liu, Peng, Zhang, Ning, Sun, Donglin, Sun, Haiming, Wu, Nan, Jin, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381560/
https://www.ncbi.nlm.nih.gov/pubmed/35973992
http://dx.doi.org/10.1038/s41420-022-01153-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381560/
https://www.ncbi.nlm.nih.gov/pubmed/35973992
http://dx.doi.org/10.1038/s41420-022-01153-8

Ejemplares similares